Ionic Levothyroxine Formulations
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/154627 |
Resumo: | Funding Information: Ana R. Jesus and Ana Rita C. Duarte acknowledge the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No ERC-2016-CoG 725034. Publisher Copyright: © 2023 by the authors. |
id |
RCAP_d4bd75e98cd51e08888ae04378f442e1 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/154627 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Ionic Levothyroxine FormulationsSynthesis, Bioavailability, and Cytotoxicity Studiescytotoxicityionic formulationslevothyroxine (T4)permeabilitysolubilityT4 based ionic liquids (T4-ILs)CatalysisMolecular BiologySpectroscopyComputer Science ApplicationsPhysical and Theoretical ChemistryOrganic ChemistryInorganic ChemistryFunding Information: Ana R. Jesus and Ana Rita C. Duarte acknowledge the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No ERC-2016-CoG 725034. Publisher Copyright: © 2023 by the authors.Thyroid diseases affect a considerable portion of the population, with hypothyroidism being one of the most commonly reported thyroid diseases. Levothyroxine (T4) is clinically used to treat hypothyroidism and suppress thyroid stimulating hormone secretion in other thyroid diseases. In this work, an attempt to improve T4 solubility is made through the synthesis of ionic liquids (ILs) based on this drug. In this context, [Na][T4] was combined with choline [Ch]+ and 1-(2-hydroxyethyl)-3-methylimidazolium [C2OHMiM]+ cations in order to prepare the desired T4-ILs. All compounds were characterized by NMR, ATR-FTIR, elemental analysis, and DSC, aiming to check their chemical structure, purities, and thermal properties. The serum, water, and PBS solubilities of the T4-ILs were compared to [Na][T4], as well as the permeability assays. It is important to note an improved adsorption capacity, in which no significant cytotoxicity was observed against L929 cells. [C2OHMiM][T4] seems to be a good alternative to the commercial levothyroxine sodium salt with promising bioavailability.DQ - Departamento de QuímicaLAQV@REQUIMTERUNBarreira, AntónioSantos, Andreia F. M.Dionísio, MadalenaJesus, Ana R.Duarte, Ana Rita C.Petrovski, ŽeljkoPaninho, Ana B.Ventura, Márcia G.Branco, Luís C.2023-06-29T22:17:50Z2023-05-162023-05-16T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article12application/pdfhttp://hdl.handle.net/10362/154627eng1661-6596PURE: 64822827https://doi.org/10.3390/ijms24108822info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T18:12:30Zoai:run.unl.pt:10362/154627Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T18:12:30Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Ionic Levothyroxine Formulations Synthesis, Bioavailability, and Cytotoxicity Studies |
title |
Ionic Levothyroxine Formulations |
spellingShingle |
Ionic Levothyroxine Formulations Barreira, António cytotoxicity ionic formulations levothyroxine (T4) permeability solubility T4 based ionic liquids (T4-ILs) Catalysis Molecular Biology Spectroscopy Computer Science Applications Physical and Theoretical Chemistry Organic Chemistry Inorganic Chemistry |
title_short |
Ionic Levothyroxine Formulations |
title_full |
Ionic Levothyroxine Formulations |
title_fullStr |
Ionic Levothyroxine Formulations |
title_full_unstemmed |
Ionic Levothyroxine Formulations |
title_sort |
Ionic Levothyroxine Formulations |
author |
Barreira, António |
author_facet |
Barreira, António Santos, Andreia F. M. Dionísio, Madalena Jesus, Ana R. Duarte, Ana Rita C. Petrovski, Željko Paninho, Ana B. Ventura, Márcia G. Branco, Luís C. |
author_role |
author |
author2 |
Santos, Andreia F. M. Dionísio, Madalena Jesus, Ana R. Duarte, Ana Rita C. Petrovski, Željko Paninho, Ana B. Ventura, Márcia G. Branco, Luís C. |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
DQ - Departamento de Química LAQV@REQUIMTE RUN |
dc.contributor.author.fl_str_mv |
Barreira, António Santos, Andreia F. M. Dionísio, Madalena Jesus, Ana R. Duarte, Ana Rita C. Petrovski, Željko Paninho, Ana B. Ventura, Márcia G. Branco, Luís C. |
dc.subject.por.fl_str_mv |
cytotoxicity ionic formulations levothyroxine (T4) permeability solubility T4 based ionic liquids (T4-ILs) Catalysis Molecular Biology Spectroscopy Computer Science Applications Physical and Theoretical Chemistry Organic Chemistry Inorganic Chemistry |
topic |
cytotoxicity ionic formulations levothyroxine (T4) permeability solubility T4 based ionic liquids (T4-ILs) Catalysis Molecular Biology Spectroscopy Computer Science Applications Physical and Theoretical Chemistry Organic Chemistry Inorganic Chemistry |
description |
Funding Information: Ana R. Jesus and Ana Rita C. Duarte acknowledge the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No ERC-2016-CoG 725034. Publisher Copyright: © 2023 by the authors. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06-29T22:17:50Z 2023-05-16 2023-05-16T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/154627 |
url |
http://hdl.handle.net/10362/154627 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1661-6596 PURE: 64822827 https://doi.org/10.3390/ijms24108822 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
12 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545940763934720 |